HAPLN4 Activators
HAPLN4 activators encompass a range of compounds that indirectly influence the activity of HAPLN4 by modifying the extracellular matrix (ECM) or cellular pathways that govern ECM dynamics. This set of compounds includes both small molecules and conditions that can lead to increased synthesis or stabilization of ECM components, consequently affecting HAPLN4, which is involved in stabilizing the ECM structure.
Compounds like ascorbic acid and copper sulfate are cofactors for enzymes that facilitate the biosynthesis and crosslinking of collagen and elastin, essential components of the ECM. By enhancing the integrity of the ECM, these compounds indirectly support the function of HAPLN4. Similarly, retinoic acid and dexamethasone influence gene expression patterns related to ECM component production. The application of osteogenic supplements such as β-glycerophosphate can promote ECM mineralization, a process in which HAPLN4 could play a role by organizing proteoglycans and hyaluronan, thereby supporting the mineralization matrix. Additionally, bioactive lipids such as lysophosphatidic acid can stimulate fibroblasts to deposit ECM, which again is conducive to the function of HAPLN4. Manganese and zinc are cofactors for enzymes in the synthesis of proteoglycans, thus potentially enhancing the ECM environment for HAPLN4 to function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Co-factor for prolyl and lysyl hydroxylase enzymes, enhancing collagen synthesis and potentially stabilizing the ECM, supporting HAPLN4 function. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Regulates gene expression, promotes ECM synthesis, thereby possibly enhancing HAPLN4 activity through increased ECM stabilization. | ||||||
β-Glycerophosphate disodium salt | 819-83-0 | sc-220452 sc-220452A sc-220452B sc-220452C sc-220452D sc-220452E | 25 g 100 g 500 g 1 kg 3 kg 6 kg | $63.00 $119.00 $442.00 $738.00 $2091.00 $3652.00 | 43 | |
Osteogenic supplement that promotes ECM mineralization, which could indirectly enhance HAPLN4 function. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can promote ECM production in certain contexts, potentially enhancing the ECM environment for HAPLN4. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Bioactive lipid that can enhance ECM deposition by fibroblasts, potentially impacting HAPLN4 function. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Essential cofactor for lysyl oxidase, which crosslinks collagen and elastin in the ECM, possibly supporting HAPLN4 activity. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Co-factor for enzymes involved in proteoglycan synthesis, which could indirectly support HAPLN4 activity through ECM stabilization. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Involved in various enzyme processes that could enhance ECM production, indirectly supporting HAPLN4 function. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Anti-inflammatory drug that can influence ECM components, potentially impacting HAPLN4 activity indirectly. | ||||||
Hyaluronic acid | 9004-61-9 | sc-337865 | 10 mg | $208.00 | ||
Major component of the ECM; its increased production or stabilization could enhance HAPLN4 function within the ECM. | ||||||